About Byron Elton
Form D filings for CancerVAX from 2023 to 2024 list Byron Elton as CEO and director.
Byron Elton first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Byron Elton in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Byron Elton works with at each company, as listed on that company's latest Form D.
CancerVAX, Inc. · Form D/A, Oct 18, 2024
CM
Carla Miller
Director